Sanofi-Aventis To Consolidate Further In India As Longtime Shareholder United Breweries Exits
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Indian liquor baron Vijay Mallya's move to sell the 10.27 percent stake that his group companies hold in the Indian unit of Paris-headquartered Sanofi-Aventis will give the multinational drug maker an "opportunity to consolidate its presence in the high-growth market," and is not seen as part of any plans to de-list the company from the Indian stock exchanges